Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tg Therapeutics (TGTX) Return on Capital Employed: 2016-2025

Historic Return on Capital Employed for Tg Therapeutics (TGTX) over the last 9 years, with Sep 2025 value amounting to 0.15%.

  • Tg Therapeutics' Return on Capital Employed rose 15.00% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 15.00%. This contributed to the annual value of 0.12% for FY2024, which is 2.00% up from last year.
  • As of Q3 2025, Tg Therapeutics' Return on Capital Employed stood at 0.15%, which was down 14.02% from 0.17% recorded in Q2 2025.
  • Tg Therapeutics' 5-year Return on Capital Employed high stood at 0.37% for Q2 2024, and its period low was -1.43% during Q4 2022.
  • Its 3-year average for Return on Capital Employed is -0.17%, with a median of 0.09% in 2024.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first surged by 203bps in 2021, then plummeted by 49bps in 2022.
  • Quarterly analysis of 5 years shows Tg Therapeutics' Return on Capital Employed stood at -1.05% in 2021, then tumbled by 38bps to -1.43% in 2022, then skyrocketed by 151bps to 0.07% in 2023, then grew by 1bps to 0.09% in 2024, then rose by 15bps to 0.15% in 2025.
  • Its Return on Capital Employed stands at 0.15% for Q3 2025, versus 0.17% for Q2 2025 and 0.13% for Q1 2025.